These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3761196)

  • 1. Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse.
    Buccafusco JJ; Aronstam RS
    J Pharmacol Exp Ther; 1986 Oct; 239(1):43-7. PubMed ID: 3761196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine protection from soman and echothiophate toxicity in mice.
    Aronstam RS; Smith MD; Buccafusco JJ
    Life Sci; 1986 Dec; 39(22):2097-102. PubMed ID: 3784771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of alpha 2-adrenergic receptor stimulation in reducing the central toxicity following cholinesterase inhibition.
    Buccafusco JJ; Li W
    Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):85-98. PubMed ID: 1352646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the clonidine-induced protection against acetylcholinesterase inhibitor toxicity.
    Buccafusco JJ
    J Pharmacol Exp Ther; 1982 Sep; 222(3):595-9. PubMed ID: 6286926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine.
    Buccafusco JJ; Graham JH; Aronstam RS
    Pharmacol Biochem Behav; 1988 Feb; 29(2):309-13. PubMed ID: 3362926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman.
    Buccafusco JJ; Graham JH; VanLingen J; Aronstam RS
    Neurotoxicol Teratol; 1989; 11(1):39-44. PubMed ID: 2725439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
    Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
    Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic mechanisms contribute to soman-induced symptoms and lethality.
    Hassel B
    Neurotoxicology; 2006 Jul; 27(4):501-7. PubMed ID: 16500708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the therapeutic efficacy of some antimuscarinics against soman in vivo.
    Lau WM; Lewis KJ; Dawson RM
    J Appl Toxicol; 1996; 16(5):423-30. PubMed ID: 8889794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection by clonidine from the cardiovascular changes and lethality following soman administration in the rat: role of brain acetylcholine.
    Magrí V; Buccafusco JJ; Aronstam RS
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):464-73. PubMed ID: 3188010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of central biogenic amines on the protection afforded by clonidine against the toxicity of soman, an irreversible cholinesterase inhibitor.
    Buccafusco JJ; Aronstam RS; Graham JH
    Toxicol Lett; 1988 Sep; 42(3):291-9. PubMed ID: 3176058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-junctional effects of oximes on [3H]-acetylcholine release in rat hippocampal slices during soman intoxication.
    Øydvin OK; Tansø R; Aas P
    Eur J Pharmacol; 2005 Jun; 516(3):227-34. PubMed ID: 15967427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of S+ ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs.
    Dorandeu F; Baille V; Mikler J; Testylier G; Lallement G; Sawyer T; Carpentier P
    Toxicology; 2007 May; 234(3):185-93. PubMed ID: 17408839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning.
    Raveh L; Chapman S; Cohen G; Alkalay D; Gilat E; Rabinovitz I; Weissman BA
    Neurotoxicology; 1999 Aug; 20(4):551-9. PubMed ID: 10499354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the effects of BI-6, a new asymmetric bipyridine oxime, with HI-6 oxime and obidoxime in combination with atropine on soman and fosdrine toxicity in mice].
    Kassa J
    Ceska Slov Farm; 1999 Jan; 48(1):44-7. PubMed ID: 10376416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonidine prevents the short-term down regulation of muscarinic receptors in mouse brain induced by the acetylcholinesterase inhibitor soman.
    Aronstam RS; Smith MD; Buccafusco JJ
    Neurosci Lett; 1987 Jul; 78(1):107-12. PubMed ID: 3614769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
    Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
    Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of guinea pigs against soman poisoning by pretreatment with p-nitrophenyl phosphoramidates.
    Langenberg JP; De Jong LP; Benschop HP
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):444-50. PubMed ID: 8887462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.